Advanced Head and Neck Squamous Cell CarcinomaLocally Advanced Head and Neck Squamous Cell CarcinomaMetastatic Head-and-neck Squamous-cell Carcinoma+3 more

PrincipalinvestigatorStart date: 2021-02-25

NCT04375384Phase 2Recruiting

Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

Head and Neck Squamous Cell CarcinomaMetastatic Head-and-neck Squamous-cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma

PrincipalinvestigatorStart date: 2020-07-01

NCT03982537Phase 2Withdrawn

Effect of N-Acetyl Cysteine (NAC) on the Oral Microbiome

Head and Neck Cancer

PrincipalinvestigatorStart date: 2020-06-18

NCT00573989Phase 1/2Terminated

Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer

Head and Neck Cancer

PrincipalinvestigatorStart date: 2008-03-01

NCT00601913Early Phase 1Completed

Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery

Head and Neck Cancer

PrincipalinvestigatorStart date: 2008-03-01

NCT00721513Phase 2Completed

Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Head and Neck Cancer

Principalinvestigator

Research Network

Collaboration Network

4 collaborators·3 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Cancer of Head and Neck4 Metastatic Head-and-neck Squamous-cell Carcinoma2 Recurrent Head and Neck Squamous Cell Carcinoma2 Advanced Head and Neck Squamous Cell Carcinoma1 Squamous Cell Carcinoma of Head and Neck1 Locally Advanced Head and Neck Squamous Cell Carcinoma1 Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck1 Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck1

Affiliations

Wake Forest University Health Sciences

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Kathryn M. Greven, MD

Wake Forest University Health Sciences

5 trials

Shared therapeutic areas:

Cancer of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)Wake Forest University Health Sciences

Collaborated on 1 trial

Similarity Score14%

J. D. Browne, MD

Wake Forest University Health Sciences

1 trials

Shared therapeutic areas:

Cancer of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)Wake Forest University Health Sciences

Collaborated on 1 trial

Similarity Score14%

Douglas Adkins, M.D.

Washington University School of Medicine

11 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckCancer of Head and NeckRecurrent Head and Neck Squamous Cell Carcinoma

Similarity Score11%

Nina Bhardwaj, MD, PhD

Icahn School of Medicine at Mount Sinai

8 trials

Shared therapeutic areas:

Cancer of Head and NeckSquamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)

Similarity Score8%

yuankai shi, MD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

17 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckCancer of Head and Neck

Similarity Score8%

Lillian Siu, MD

Princess Margaret Cancer Centre

12 trials

Shared therapeutic areas:

Cancer of Head and NeckSquamous Cell Carcinoma of Head and Neck

Similarity Score8%

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

18 trials

Shared therapeutic areas:

Cancer of Head and NeckSquamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)

Similarity Score8%

Ye Guo, MD

Fudan University

13 trials

Shared therapeutic areas:

Cancer of Head and NeckSquamous Cell Carcinoma of Head and Neck

Similarity Score8%

Ingrid Mayer, MD

Vanderbilt-Ingram Cancer Center

13 trials

Shared therapeutic areas:

Cancer of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)

Similarity Score4%

Vincent Chung

City of Hope Medical Center

9 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)

Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT04454489Phase 2PrincipalInvestigator

Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition

Advanced Head and Neck Squamous Cell CarcinomaLocally Advanced Head and Neck Squamous Cell CarcinomaMetastatic Head-and-neck Squamous-cell Carcinoma+3 more

Completed

NCT04375384Phase 2PrincipalInvestigator

Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer

Head and Neck Squamous Cell CarcinomaMetastatic Head-and-neck Squamous-cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma

Recruiting

NCT03982537Phase 2PrincipalInvestigator

Effect of N-Acetyl Cysteine (NAC) on the Oral Microbiome

Head and Neck Cancer

Withdrawn

NCT00573989Phase 1/2PrincipalInvestigator

Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer

Head and Neck Cancer

Terminated

NCT00601913Early Phase 1PrincipalInvestigator

Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery

Head and Neck Cancer

Completed

NCT00721513Phase 2PrincipalInvestigator

Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Head and Neck Cancer

Completed

All 6 trials loaded